An AI, err ma­chine learn­ing, shop lines up Eli Lil­ly as part­ner ahead of first in-house clin­i­cal tri­al

Life sci­ences soft­ware de­vel­op­er and drug dis­cov­ery out­fit Schrödinger, dur­ing its “plat­form day,” out­lined its pro­grams and path for­ward two months af­ter bring­ing on board long-time biotech an­a­lyst Ge­of­frey Porges, who told End­points News on his first day that the com­pa­ny’s sto­ry had been “over-sim­pli­fied.”

As part of telling its sto­ry on Thurs­day, which in­clud­ed slides of Schrödinger cats, the New York-based com­pa­ny dis­closed an­oth­er part­ner, adding to the dozen or so col­lab­o­ra­tions in the works at Schrödinger.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER